加味寿胎丸联合黄体酮调节NKG2D、NKG2A表达治疗肾虚型URSA作用机制研究
Study on the Action Mechanism of Combined Jiaweishoutai Wan and Progesterone in Regulating NKG2D and NKG2A Expression for Treating URSA of Kidney Deficiency Type
-
摘要: 目的 探讨NK细胞活性变化在不明原因复发性流产(URSA)发病中的机制;加味寿胎丸联合黄体酮通过调节NK细胞受体表达变化诱导母胎免疫耐受治疗URSA的作用机制。方法 选取加味寿胎丸联合黄体酮治疗肾虚型URSA成功患者20例,并选取同期URSA妊娠丢失组及健康早孕(HEP)组各15例,以流式细胞术检测各组外周血NKG2D、NKG2A的表达,并比较URSA妊娠组治疗后与健康早孕组血E2、P、β-HCG水平。结果 URSA妊娠丢失组pNK细胞NKG2D呈高表达及NKG2A呈低表达,与HEP组比较有显著统计学意义(P<0.01)。URSA妊娠组治疗后pNK细胞NKG2D表达水平明显低于治疗前,与HEP组比较有统计学意义(P<0.05),与URSA妊娠丢失组比较有显著统计学意义(P<0.01);NKG2A表达水平明显高于治疗前(P<0.01),与HEP组比较无统计学意义,与URSA妊娠丢失组比较有显著统计学意义(P<0.01)。经加味寿胎丸联合黄体酮治疗后,URSA妊娠组血清E2、P、β-HCG水平与HEP组分别比较,差异均无统计学意义(P>0.05)。结论 NK细胞受体NKG2D、NKG2A的表达参与了URSA的发病;加味寿胎丸联合黄体酮能通过下调URSA患者NKG2D的表达水平,上调NKG2A的表达水平介导母胎免疫耐受治疗URSA;固肾安胎法是治疗肾虚型URSA的有效方法,加味寿胎丸是治疗肾虚型URSA的有效方剂。Abstract: OBJECTIVE To investigate NK cells activity changes in the occurrence of URSA, and explain the action mechanism of combined Gushen Antai experienced formula "Jiaweishoutai Wan" and progesterone in the treatment of URSA by regulating expression changes of NK cell receptor to induce immune tolerance. METHODS Twenty patients with kidney deficiency type URSA successfully treated by combined Jiaweishoutai Wan and progesterone were chosen. And URSA pregnancy loss patients and HEP patients at the same period were selected, 15 cases in each group. The expression of NKG2D and NKG2A in peripheral blood were detected by flow cytometry. The levels of E2, P and β-HCG in the URSA pregnancy group and HEP group were compared after treatment. RESULTS In URSA pregnancy loss group, the expression of NKG2D of NK cells was higher and NKG2A was lower, the differences were statistically different compared with HEP group (P<0.01). NKG2D expression level of pNK cells in URSA pregnancy group was significantly lower than that of pretreatment, and the difference was statistically different compared with URSA pregnancy loss group (P<0.01); and the NKG2A expression level was obviously higher than that of pretreatment (P<0.01), the difference was not statistically significant compared with HEP group, and the difference was statistically different compared with URSA pregnancy loss group (P<0.01). After treating with combined Jiaweishoutai Wan and progesterone, the blood serum E2, P and β-HCG levels in URSA pregnancy group were all not significantly different with that in the HEP group (P>0.05). CONCLUSION The expression of NK cells receptors including NKG2D and NKG2A is involving in the occurrence of URSA. The combined Jiaweishoutai Wan and progesterone can treat URSA by down regulating the NKG2D expression levels of URSA patients and up regulating NKG2A expression levels to induce maternal fetal immune tolerance. Gushen Antai method is an effective treating method for URSA of kidney deficiency type. Jiaweishoutai Wan is an effective formula for treating URSA of kidney deficiency type.
-
Key words:
- Jiaweishoutai Wan /
- progesterone /
- URSA /
- NKG2D /
- NKG2A /
- NK cells /
- kidney deficiency
-
[1] 张建平,林其德,李大金,等.复发性流产的诊断与治疗[J].现代妇产科进展,2006,15(7):481-492. [2] ZHANG JP, LIN QD, LI DJ, et al. Diagnosis and treatment of recurrent spontaneous abortion[J]. Progr Obstetr Gynecol, 2006,15(7):481-492. [3] 田志刚.NK细胞研究现状的分析[J].中国肿瘤生物治疗杂志,1999,6(1):1-3. [4] TIAN ZG. Analysis of NK cell research status[J]. Chin J Cancer Biother, 1999,6(1):1-3. [5] 谢幸,苟文丽.妇产科学[M].北京:人民卫生出版社,2013:47-49,168. [6] XIE X, GOU WL. Obstetrics and Gynecology Sciences[M]. Beijing: People's medical publishing house, 2013:47-49,168. [7] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2010:311-313. [8] CAO ZY. Chinese Obstetrics and Gynecology[M]. Beijing: People's medical publishing house, 2010:311-313. [9] 中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:253-256,385-392. [10] Guideline for Clinical Trials of New Patent Chinese Medicines (Trial Implementation)[M]. Beijing: China medical science and technology press, 2002:253-256, 385-392. [11] 张玉珍.中医妇科学[M].北京:中国中医药出版社,2002:208-212,217-220. [12] ZHANG YZ. Gynecology of Chinese Medicine[M]. Beijing: China press of traditional Chinese medicine,2002:208-212, 217-220. [13] 朱文峰.中医诊断学[M].北京:中国中医药出版社,2007:189-191. [14] ZHU WF. Diagnostics of Chinese Medicine[M]. Beijing: China press of traditional Chinese medicine,2007:189-191. [15] 萧埙.女科经纶[M].北京:中医古籍出版社,1999:51. [16] XIAO X. Profound Scholarship in Gynecology[M]. Beijing: Traditional Chinese medicine classics press, 1999:51. [17] 齐仲甫.女科百问[M].天津:天津科学技术出版社,1999:51. [18] QI ZF. One Hundred Questions on Gynecology[M]. Tianjin: Tianjin science and technology press, 1999:51. [19] 张介宾.景岳全书[M].上海:上海科学技术出版社,1959:657. [20] ZHANG JB. The Complete Works of Jing-yue[M]. Shanghai: Shanghai science and technology press, 1959:657. [21] 林其德,邱丽华.原因不明复发性流产与母胎界面免疫耐受[J].中华妇产科杂志,2006,41(3):145. [22] LIN QD, QIU LH. Studies on the relationship between unexplained recurrent spontaneous abortion and immunotolerance at the maternal-fetal interface[J]. Chin J Obstet Gynecol, 2006, 41(3):145. [23] PARK YP, CHOI SC, KIESLER P, et al. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the yc cytokines and TGF-β1[J]. Blood, 2011, 118(11): 3019-3027. [24] MORETTA L, MORETTA A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors[J]. EMBO J, 2004, 23(2): 255-259. [25] 余琴梅,陈琳琳,王文静,等.白介素10可保持蜕膜NKG2D+TGF-β-NK细胞低水平并有利于妊娠成功[J].现代免疫学,2011,31(2):139-142. [26] YU QM, CHEN LL, WANG WJ, et al. Interleukin 10 can maintain the low levels of decidual NKG2D+TGF-β-NK cells and is beneficial to the success of pregnancy[J]. Cur Immunol, 2011, 31(2):139-142. [27] 赵丽丽,曲迅,孔北华,等.妊娠期uNK、pNK细胞NKG2A与NKG2D的表达及其生物学意义的研究[J].中国免疫学杂志,2005,21(7):518-520. [28] ZHAO LL, QU X, KONG BH, et al. The expression of NKG2A and NKG2D and their biological significance on decidual NK cells and peripheral NK cells in pregnancy[J]. Chin J Immun, 2005, 21(7):518-520.
点击查看大图
计量
- 文章访问数: 1227
- HTML全文浏览量: 5
- PDF下载量: 1070
- 被引次数: 0